tailieunhanh - báo cáo khoa học: " Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK | Harm Reduction Journal BioMed Central Open Access Methodology for the Randomised Injecting Opioid Treatment Trial RIOTT evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK Nicholas Lintzeris 1 3 John Strang1 Nicola Metrebian1 Sarah Byford1 Christopher Hallam2 Sally Lee1 Deborah Zador4 and RIOTT Group Address 1Institute of Psychiatry King s College London 16 De Crespigny Park London SE5 8AF UK 2The Alliance Room 312 Panther House 38 Mount Pleasant London WC1X 0AN UK 3National Drug and Alcohol Research Centre University of New South Wales Sydney 2052 Australia and 4South London and Maudsley NHS Trust. Denmark Hill London SE5 8AF UK Email Nicholas Lintzeris - John Strang - Nicola Metrebian - Sarah Byford - Christopher Hallam - christopher_hallam@ Sally Lee - Deborah Zador - RIOTT Group - Corresponding author Published 27 September 2006 Received 28 March 2006 __ AA J inli z Accepted 27 September 2006 Harm Reduction Journal 2006 3 28 doi 1477-7517-3-28 This article is available from http content 3 1 28 2006 Lintzeris et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Whilst unsupervised injectable methadone and diamorphine treatment has been part of the British treatment system for decades the numbers receiving injectable opioid treatment IOT has been steadily diminishing in recent years. In contrast there has been a recent expansion of supervised injectable diamorphine programs under trial conditions in